Literature DB >> 11513874

Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain.

M L Patterson1, S J Atkinson, V Knäuper, G Murphy.   

Abstract

In view of the essential role of the hemopexin domain of the traditional interstitial collagenases, MMP-1, -8, -13 and MT1-MMP (MMP-14), in determining specific collagen cleavage we have studied the function of this domain in MMP-2, relative to that of the fibronectin-like domain that promotes gelatinolysis. Although the fibronectin-like domain promotes avid binding to collagen, our data demonstrate that the catalytic and hemopexin domains of MMP-2 are sufficient to effect the critical step in cleavage of rat type I collagen into 3/4 and 1/4 fragments. The mechanism of MMP-2 cleavage of collagen proceeds in two phases, the first resembling that of the interstitial collagenases, followed by gelatinolysis, promoted by the fibronectin-like domain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513874     DOI: 10.1016/s0014-5793(01)02723-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  53 in total

1.  Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Authors:  Poulami Basu; Natia Qipshidze; Utpal Sen; Srikanth Givvimani; Charu Munjal; Paras K Mishra; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-08-13       Impact factor: 4.076

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

3.  Association of MMP-2 expression and prognosis in osteosarcoma patients.

Authors:  Miao Zhang; Xuran Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 4.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 5.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 6.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

7.  Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains.

Authors:  Susanna Monaco; Valentina Sparano; Magda Gioia; Diego Sbardella; Donato Di Pierro; Stefano Marini; Massimo Coletta
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

Review 8.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

9.  Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome.

Authors:  Pascal Schlage; Fabian E Egli; Paolo Nanni; Lauren W Wang; Jayachandran N Kizhakkedathu; Suneel S Apte; Ulrich auf dem Keller
Journal:  Mol Cell Proteomics       Date:  2013-11-26       Impact factor: 5.911

10.  Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.

Authors:  Linda Chung; Deendayal Dinakarpandian; Naoto Yoshida; Janelle L Lauer-Fields; Gregg B Fields; Robert Visse; Hideaki Nagase
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.